1. Home
  2. SRDX vs FBIZ Comparison

SRDX vs FBIZ Comparison

Compare SRDX & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • FBIZ
  • Stock Information
  • Founded
  • SRDX 1979
  • FBIZ 1909
  • Country
  • SRDX United States
  • FBIZ United States
  • Employees
  • SRDX N/A
  • FBIZ N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • FBIZ Major Banks
  • Sector
  • SRDX Health Care
  • FBIZ Finance
  • Exchange
  • SRDX Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • SRDX 415.4M
  • FBIZ 396.0M
  • IPO Year
  • SRDX 1998
  • FBIZ N/A
  • Fundamental
  • Price
  • SRDX $31.10
  • FBIZ $53.82
  • Analyst Decision
  • SRDX Buy
  • FBIZ Strong Buy
  • Analyst Count
  • SRDX 2
  • FBIZ 4
  • Target Price
  • SRDX $43.00
  • FBIZ $56.50
  • AVG Volume (30 Days)
  • SRDX 89.7K
  • FBIZ 59.5K
  • Earning Date
  • SRDX 07-30-2025
  • FBIZ 07-24-2025
  • Dividend Yield
  • SRDX N/A
  • FBIZ 2.15%
  • EPS Growth
  • SRDX N/A
  • FBIZ 26.78
  • EPS
  • SRDX N/A
  • FBIZ 5.48
  • Revenue
  • SRDX $121,575,000.00
  • FBIZ $148,866,000.00
  • Revenue This Year
  • SRDX N/A
  • FBIZ $18.39
  • Revenue Next Year
  • SRDX $3.70
  • FBIZ $7.81
  • P/E Ratio
  • SRDX N/A
  • FBIZ $9.84
  • Revenue Growth
  • SRDX N/A
  • FBIZ 9.38
  • 52 Week Low
  • SRDX $26.00
  • FBIZ $38.72
  • 52 Week High
  • SRDX $42.25
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 66.72
  • FBIZ 61.70
  • Support Level
  • SRDX $30.54
  • FBIZ $52.11
  • Resistance Level
  • SRDX $31.47
  • FBIZ $54.22
  • Average True Range (ATR)
  • SRDX 0.93
  • FBIZ 1.25
  • MACD
  • SRDX 0.21
  • FBIZ 0.28
  • Stochastic Oscillator
  • SRDX 95.58
  • FBIZ 72.76

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: